Home » Topics » Regulatory

Regulatory
RSS

Phase II trial to compare two ciprofloxacin formulations for urinary tract infections

Oct. 4, 2001

Atrix submits NDA for Leuprogel Three-Month Depot for prostate cancer

Sep. 28, 2001

sBLA submitted for ARANESP

Sep. 25, 2001

New strength of Zomig-ZMT approved by FDA

Sep. 21, 2001

More flexible and personalized therapy now possible with NeoRecormon

Sep. 20, 2001

FDA grants priority review status to etanercept for treatment of psoriatic arthritis

Sep. 19, 2001

Adapalene and pharmaceutical compositions thereof for use in cancer therapy

Sep. 17, 2001

Pump therapy with insulin aspart approved by EMEA

Sep. 14, 2001

Plavix sNDA granted FDA priority review

Sep. 13, 2001

Allergan's Botox cleared in Canada for treatment of axillary hyperhidrosis

Sep. 13, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...